Celanese Corp. (CE) Misses Q4 EPS by 4c, Sales Top Expectations
Tweet
Share
E-mailGet Alerts CE Hot Sheet
Price: $44.67 --0%
EPS Growth %: +20.9%
Financial Fact:
Net earnings (loss) - diluted: 1.81
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +20.9%
Financial Fact:
Net earnings (loss) - diluted: 1.81
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Celanese Corp. (NYSE: CE) reported Q4 adjusted EPS of $0.58, $0.04 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $1.61 billion versus the consensus estimate of $1.56 billion.
Celanese Corp. sees FY2012 EPS above $4.70, versus the consensus of $4.78.
For earnings history and earnings-related data on Celanese Corp. (CE) click here.
Celanese Corp. sees FY2012 EPS above $4.70, versus the consensus of $4.78.
For earnings history and earnings-related data on Celanese Corp. (CE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Barclays Downgrades Ipsen SA (IPN:FP) (IPSEF) to Underweight
- Solaris Energy raises 2026 guidance, initiates Q1 2027 outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
